Your top news on business and economy

Provided by AGP

Business Post Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Business Post Examiner.

Press releases published on April 11, 2026

Upcoming National Women’s Health Week: Promoting Scalp Care and Breathable Wig Solutions
BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer
BioNTechs und DualityBios Antikörper-Wirkstoff-Konjugat-Kandidat Trastuzumab Pamirtecan zeigte klinisch relevante Wirksamkeit bei Patientinnen mit rezidivierendem HER2-exprimierendem Gebärmutterkrebs
'The Charm of Chunhyang Captivates the World' 96th Namwon Chunhyang Festiva Kicks Off on April 30
City Furniture and GARVEE Explore Omnichannel Retail Collaboration in North America
Cookiy Introduces a User Research Suite That Enables Any AI to Talk to Real People
Changing Life & Destiny Conference to Honor Dylan Gemelli with the CLD 2026 Wellness Educator Award
Umbrella Lab Announces RUO Documentation And Traceability Update For MSCs Exosomes
KWM、BTS、セブンティーン、ル・セラフィムなどを対象とした独占的グローバル配給契約をハイブと締結、目標の年間売上高は1億ドル (約160億円) 超
KWM 与 HYBE 签署覆盖 BTS、 SEVENTEEN 和 LE SSERAFIM 等的全球独家发行协议,目标年收入超过 1 亿美元
KWM, HYBE와 BTS·세븐틴·르세라핌 등 포함한 글로벌 독점 유통 계약 체결… 연매출 1억 달러 이상 목표
KWM Menandatangani Perjanjian Pengedaran Eksklusif Global dengan HYBE yang Merangkumi BTS, SEVENTEEN, LE SSERAFIM dan Lain-lain — Menyasarkan Pendapatan Tahunan Melebihi AS$100 Juta
KWM 與 HYBE 簽訂獨家全球分銷協議,涵蓋 BTS、SEVENTEEN、LE SSERAFIM 等多名藝人,劍指年度收入突破 1 億美元
NeuroSalt Under Investigation: What the 2026 Formulation Transparency Review Reveals About Botanical Ingredients, Dosage Disclosure, and Consumer Verification
Alleron Expert Group Marks Six Years of 100% Client Retention, Announces Expanded Cloud Services Portfolio
Digital Asset Technologies Inc. Announces Intention to Amend and Refile Financial Statements and MD&A
Pulsetto Claims Evaluated: 2026 Update on the Pulsetto Vagus Nerve Stimulator, Features, Pricing, and Consumer Use Considerations
IMMP Investor News: If You Have Suffered Losses in Immutep Ltd. (NASDAQ: IMMP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Digital Asset Technologies Inc. Clarifying News Release
KYNDRYL DEADLINE: ROSEN, NATIONAL INVESTOR RIGHTS COUNSEL, Encourages Kyndryl Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 13 Deadline in Securities Class Action First Filed by the Firm – KD

Share us

on your social networks:

Sign up for:

Business Post Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.